Maven Securities LTD Essa Pharma Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$7.76 - $29.37 $137,437 - $520,172	-17,711 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$24.17 - $34.28 $250,594 - $355,415	-10,368 Reduced 36.92%	17,711 $512,000
Q1 2021 May 17, 2021	SELL	$11.61 - $32.08 $78,030 - $215,609	-6,721 Reduced 19.31%	28,079 $840,000
Q4 2020 Feb 12, 2021	BUY	$5.47 - $12.1 $190,356 - $421,080	34,800 New	34,800 $415,000

35.1M

15.8K

21K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $80.7M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.